Southernbiotech ：

SBA（Southern Biotechnology Associates, Inc.或簡(jiǎn)稱(chēng)SouthernBiotech） 公司建于1982年，由美國(guó)伯明翰的阿拉巴馬大學(xué)（UAB）的Dr. Max  Cooper細(xì)胞免疫學(xué)實(shí)驗(yàn)室的科學(xué)家創(chuàng)建。SBA致力于高質(zhì)量、高親和純化的二抗的生產(chǎn)、純化和標(biāo)記。  同時(shí)，SBA還提供各種親和純化的多克隆和單克隆抗體，其中包括：熒光素和酶標(biāo)記物，低內(nèi)毒素/不含疊氮化物（LE/AF）制劑，F(xiàn)(ab)和 F(ab')2片段化抗體，此外還有純化的免疫球蛋白、血清以及細(xì)胞外基質(zhì)蛋白等產(chǎn)品。作為SBA的中國(guó)區(qū)域代理，科技有限公司憑借豐富的專(zhuān)業(yè)經(jīng)驗(yàn)，將一如既往的為中國(guó)區(qū)域客戶(hù)提供SBA優(yōu)質(zhì)的產(chǎn)品和技術(shù)服務(wù)。

Southernbiotech代理書(shū):

的備受推崇的學(xué)者、的制藥企業(yè)以及的生物技術(shù)公司都在使用SouthernBiotech產(chǎn)品。相比普通方法的產(chǎn)品而言，SBA提供的產(chǎn)品 在科研分析過(guò)程中更靈敏、更有效。SouthernBiotech的客戶(hù)和技術(shù)轉(zhuǎn)讓合作伙伴包括大部分世界的制藥、生物技術(shù)和學(xué)術(shù)研究實(shí)驗(yàn)室，其產(chǎn)品 通過(guò)專(zhuān)門(mén)的銷(xiāo)售隊(duì)伍和遍布的經(jīng)銷(xiāo)商進(jìn)行銷(xiāo)售?？萍甲鳛镾outhernBiotech品牌在中國(guó)區(qū)域的代理，為中國(guó)客戶(hù)提供完整的免疫診斷 和檢測(cè)抗體和試劑方案。

SouthernBiotechnology Associates, Inc., now known as SouthernBiotech, was founded in 1982, by scientists from Dr. Max Cooper’s Cellular Immunology Laboratory at the University of Alabama in Birmingham (UAB), as a company dedicated to the production, purification, conjugation and commercialization of the world’s highest quality, affinity purified, secondary antibodies for research use. As a result of ongoing internal product development and our acquisition of monoclonal antibody producing cell lines through technology transfer arrangements with leading research universities and institutions, we now provide a broad range of affinity purified, polyclonal and monoclonal antibodies, including, fluorochrome and enzyme conjugates, Low Endotoxin/Azide Free (LE/AF) preparations, F(ab) and F(ab’)2 fragments, as well as, purified immunoglobulins and collagens. In addition to direct and OEM sales, our products are available through a global network, including, Fisher Scientific in the U.S. and other distributors throughout Europe, Asia, Africa, the Middle East, South America and the Pacific Rim. Our customers and technology transfer partners include most of the world’s leading pharmaceutical, biotechnology and academic research laboratories.